<DOC>
	<DOCNO>NCT01312402</DOCNO>
	<brief_summary>This study prospective , single crossover , double-masked , control clinical trial use topical brinzolamide ( Azopt ) ophthalmic medication try improve nystagmus visual consequence nystagmus patient infantile nystagmus syndrome ( INS ) . Subjects undergo clinical exam , questionnaire eye movement recording day 1 receive either topical Azopt placebo three time day eye day 2,3 4 follow morning day 5 repeat clinical exam , questionnaire eye movement recording . After least one week , protocol repeat crossover regimen take subject . One week medication discontinue , another clinical exam do study discharge . The hypothesis nystagmus associate visual symptom improve Azopt compare placebo . There total 5 visit 1-2 month period .</brief_summary>
	<brief_title>Topical Brinzolamide Ophthalmic Suspension Versus Placebo Treatment Infantile Nystagmus Syndrome</brief_title>
	<detailed_description>5 subject expect enrol study . Each subject study approximately 1 month . Efficacy assess : - ETDRS Visual Acuity Testing Binocular Best Corrected Visual Acuity In The Nystagmus Null Zone - The Validated Amblyopia &amp; Strabismus Ocular Motor Questionnaire - Eye Movement Recording Data Analysis The Nystagmus Waveform Safety evaluate : - Ocular sign symptom - Visual acuity ( uncorrected best correct ) - Slit lamp exam Intraocular Pressure - Systemic sign symptom</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Nystagmus , Pathologic</mesh_term>
	<mesh_term>Brinzolamide</mesh_term>
	<criteria>Age ; great 12 year old able cooperate full study protocol Subject able understand sign inform consent Subject able participate complete ophthalmic ocular motility evaluation Subjects Infantile Nystagmus Syndrome diagnose clinical evaluation eye movement recording Bestbinocular visual acuity null position 20/50 20/200 inclusive use ATS ETDRS vision test Subject/family able willing make require study visit No previous ophthalmic treatment nystagmus refractive error Any current use systemic topical medication ( traditional nontraditional ) History ocular surgery , trauma chronic ocular disease amblyopia Systemic disease require medication treatment know affect ocular motor system ( e.g. , depression , seizure disorder , psychosis ) Behavioral neurological disorder interfere study Physical mental impairment preclude study compliance Participation study involve IND investigational drug within past year Individual ( female ) pregnant , nurse planning pregnancy ( The safety Azopt use pregnancy NOT determine . ) Periodicity aperiodicity INS present eye movement recording Allergy sulfa component Azopt solution</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2014</verification_date>
</DOC>